immune system
• mutant T cells have a defect in T cell receptor signaling, resulting in reduced negative thymocyte selection
|
• mutant T cells have a defect in T cell receptor signaling, resulting in defects in positive selection of thymocytes
|
• CD4+ CD8+ DP thymocytes express very low levels of CD5
|
• thymocytes of homozygous mutant mice have a partial block in T cell development at the pre-T cell receptor (pre-TCR) checkpoint
|
• homozygous mutant mice have few naive CD4+ and CD8+ single-positive T cells
|
• homozygotes have 5-fold fewer CD4+ CD8+ (DP) and significantly fewer CD4+ CD8- and CD4- CD8+ SP thymocytes than wild-type controls
|
• homozygous mutant mice exhibit elevated levels of serum IgE
|
• homozygous mutant mice exhibit hypergammaglobulinemia
|
• mutant T cells have a defect in T cell receptor signaling, resulting in defects in positive selection of thymocytes and reduced negative thymocyte selection; this phenotype is cell-intrinsic
|
• homozygous mutants exhibit autoimmunity
|
hematopoietic system
• mutant T cells have a defect in T cell receptor signaling, resulting in reduced negative thymocyte selection
|
• mutant T cells have a defect in T cell receptor signaling, resulting in defects in positive selection of thymocytes
|
• CD4+ CD8+ DP thymocytes express very low levels of CD5
|
• thymocytes of homozygous mutant mice have a partial block in T cell development at the pre-T cell receptor (pre-TCR) checkpoint
|
• homozygous mutant mice have few naive CD4+ and CD8+ single-positive T cells
|
• homozygotes have 5-fold fewer CD4+ CD8+ (DP) and significantly fewer CD4+ CD8- and CD4- CD8+ SP thymocytes than wild-type controls
|
• homozygous mutant mice exhibit elevated levels of serum IgE
|
• homozygous mutant mice exhibit hypergammaglobulinemia
|
• mutant T cells have a defect in T cell receptor signaling, resulting in defects in positive selection of thymocytes and reduced negative thymocyte selection; this phenotype is cell-intrinsic
|
endocrine/exocrine glands
• homozygotes have 5-fold fewer CD4+ CD8+ (DP) and significantly fewer CD4+ CD8- and CD4- CD8+ SP thymocytes than wild-type controls
|